181 related articles for article (PubMed ID: 36034446)
1. Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver disease.
Gao R; Wang J; He X; Wang T; Zhou L; Ren Z; Yang J; Xiang X; Wen S; Yu Z; Ai H; Wang Y; Liang H; Li S; Lu Y; Zhu Y; Shi G; Chen Y
Front Endocrinol (Lausanne); 2022; 13():967016. PubMed ID: 36034446
[TBL] [Abstract][Full Text] [Related]
2. Microarray-Based Detection of Critical Overexpressed Genes in the Progression of Hepatic Fibrosis in Non-Alcoholic Fatty Liver Disease: A Protein-Protein Interaction Network Analysis.
Mahmoudi A; Butler AE; De Vincentis A; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2023 May; ():. PubMed ID: 37194229
[TBL] [Abstract][Full Text] [Related]
3. (-)-Epigallocatechin-3-gallate and atorvastatin treatment down-regulates liver fibrosis-related genes in non-alcoholic fatty liver disease.
Ying L; Yan F; Zhao Y; Gao H; Williams BR; Hu Y; Li X; Tian R; Xu P; Wang Y
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1180-1191. PubMed ID: 28815679
[TBL] [Abstract][Full Text] [Related]
4. FOXA3 induction under endoplasmic reticulum stress contributes to non-alcoholic fatty liver disease.
Liu C; Zhou B; Meng M; Zhao W; Wang D; Yuan Y; Zheng Y; Qiu J; Li Y; Li G; Xiong X; Bian H; Zhang H; Wang H; Ma X; Hu C; Xu L; Lu Y
J Hepatol; 2021 Jul; 75(1):150-162. PubMed ID: 33548387
[TBL] [Abstract][Full Text] [Related]
5. Dynamic co-expression modular network analysis in nonalcoholic fatty liver disease.
Zheng J; Wu H; Zhang Z; Yao S
Hereditas; 2021 Aug; 158(1):31. PubMed ID: 34419146
[TBL] [Abstract][Full Text] [Related]
6. Identification of disease-related genes and construction of a gene co-expression database in non-alcoholic fatty liver disease.
Ye H; Sun M; Su M; Chen D; Liu H; Ma Y; Luo W; Li H; Xu F
Front Genet; 2023; 14():1070605. PubMed ID: 37051599
[No Abstract] [Full Text] [Related]
7. Characterization of transcriptional modules related to fibrosing-NAFLD progression.
Lou Y; Tian GY; Song Y; Liu YL; Chen YD; Shi JP; Yang J
Sci Rep; 2017 Jul; 7(1):4748. PubMed ID: 28684781
[TBL] [Abstract][Full Text] [Related]
8. Weighted Gene Co-Expression Network Analysis of Immune Infiltration in Nonalcoholic Fatty Liver Disease.
Wang Z; Xia Y; Pan Y; Zhang L; Tang F; Yu X; Yang Z; Wang D; Yang L; Jia J; Yuan G
Endocr Metab Immune Disord Drug Targets; 2023; 23(9):1173-1185. PubMed ID: 36503447
[TBL] [Abstract][Full Text] [Related]
9. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD.
González-Rodríguez A; Mayoral R; Agra N; Valdecantos MP; Pardo V; Miquilena-Colina ME; Vargas-Castrillón J; Lo Iacono O; Corazzari M; Fimia GM; Piacentini M; Muntané J; Boscá L; García-Monzón C; Martín-Sanz P; Valverde ÁM
Cell Death Dis; 2014 Apr; 5(4):e1179. PubMed ID: 24743734
[TBL] [Abstract][Full Text] [Related]
10. Identification of core gene networks and hub genes associated with progression of non-alcoholic fatty liver disease by RNA sequencing.
Hotta K; Kikuchi M; Kitamoto T; Kitamoto A; Ogawa Y; Honda Y; Kessoku T; Kobayashi K; Yoneda M; Imajo K; Tomeno W; Nakaya A; Suzuki Y; Saito S; Nakajima A
Hepatol Res; 2017 Dec; 47(13):1445-1458. PubMed ID: 28219123
[TBL] [Abstract][Full Text] [Related]
11. Single-cell transcriptomics identifies Col1a1 and Col1a2 as hub genes in obesity-induced cardiac fibrosis.
Pan X; Chen X; Ren Q; Yue L; Niu S; Li Z; Zhu R; Chen X; Jia Z; Zhen R; Ban J; Chen S
Biochem Biophys Res Commun; 2022 Aug; 618():30-37. PubMed ID: 35714568
[TBL] [Abstract][Full Text] [Related]
12. Identification of ribosomal protein family as immune-cell-related biomarkers of NAFLD by bioinformatics and experimental analyses.
Li G; Li H; Chen Z
Front Endocrinol (Lausanne); 2023; 14():1161269. PubMed ID: 37274336
[TBL] [Abstract][Full Text] [Related]
13. LUM is the hub gene of advanced fibrosis in nonalcoholic fatty liver disease patients.
Chang Y; He J; Xiang X; Li H
Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101435. PubMed ID: 32386798
[TBL] [Abstract][Full Text] [Related]
14. A Comparison of the Gene Expression Profiles of Non-Alcoholic Fatty Liver Disease between Animal Models of a High-Fat Diet and Methionine-Choline-Deficient Diet.
Alshawsh MA; Alsalahi A; Alshehade SA; Saghir SAM; Ahmeda AF; Al Zarzour RH; Mahmoud AM
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164140
[TBL] [Abstract][Full Text] [Related]
15. Expression of immune related genes and possible regulatory mechanisms in different stages of non-alcoholic fatty liver disease.
He R; Guan C; Zhao X; Yu L; Cui Y
Front Immunol; 2024; 15():1364442. PubMed ID: 38524129
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hub Genes and Pathways Associated With Idiopathic Pulmonary Fibrosis
Wan H; Huang X; Cong P; He M; Chen A; Wu T; Dai D; Li W; Gao X; Tian L; Liang H; Xiong L
Front Mol Biosci; 2021; 8():711239. PubMed ID: 34476240
[TBL] [Abstract][Full Text] [Related]
17. Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.
Di Mauro S; Scamporrino A; Petta S; Urbano F; Filippello A; Ragusa M; Di Martino MT; Scionti F; Grimaudo S; Pipitone RM; Privitera G; Di Pino A; Scicali R; Valenti L; Dongiovanni P; Fracanzani A; Rabuazzo AM; Craxì A; Purrello M; Purrello F; Piro S
Liver Int; 2019 Sep; 39(9):1742-1754. PubMed ID: 31169972
[TBL] [Abstract][Full Text] [Related]
18. Validating candidate biomarkers for different stages of non-alcoholic fatty liver disease.
Al-Qarni R; Iqbal M; Al-Otaibi M; Al-Saif F; Alfadda AA; Alkhalidi H; Bamehriz F; Hassanain M
Medicine (Baltimore); 2020 Sep; 99(36):e21463. PubMed ID: 32898995
[TBL] [Abstract][Full Text] [Related]
19. Bladder cancer stage-associated hub genes revealed by WGCNA co-expression network analysis.
Di Y; Chen D; Yu W; Yan L
Hereditas; 2019; 156():7. PubMed ID: 30723390
[TBL] [Abstract][Full Text] [Related]
20. Integrative network-based analysis on multiple Gene Expression Omnibus datasets identifies novel immune molecular markers implicated in non-alcoholic steatohepatitis.
Zhang JJ; Shen Y; Chen XY; Jiang ML; Yuan FH; Xie SL; Zhang J; Xu F
Front Endocrinol (Lausanne); 2023; 14():1115890. PubMed ID: 37008925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
